Latest Shriram Finance Rallies 4% Following Nifty 50 Inclusion, UPL Dips 2% After Being Dropped Nifty 50 market news today: Shriram Finance joins Nifty 50, surges 4%; UPL exits, slips 2%. Nifty Next 50 reshuffles detailed.
Post Market Report POST-MARKET SUMMARY 28th February 2024 On February 28, the Indian equity benchmarks concluded with a decline of over 1%, marked by widespread selling across sectors. Top Gainer: HINDUNILVR | Top Loser: POWERGRID
Latest Stock Market Correction | Nifty breaches 22,000, Sensex sheds 790 points: Investment Strategy & Action Plan! Explore stock market correction opportunities and investment strategies to navigate downturns with confidence in this blog post.
Latest Exicom Tele-Systems IPO: Will this Power house charge up your Portfolio Get a detailed overview of Exicom Tele-Systems Ltd IPO, including GMP, subscription status, verdict, issue details, and the company's strengths and risks.
Post Market Report POST-MARKET SUMMARY 27th February 2024 On February 27, the Indian benchmark indices rebounded significantly from recent losses to finish in positive territory, with the Nifty hovering around 22,200. Top Gainer: TATAMOTORS | Top Loser: HEROMOTOCO
Post Market Report POST-MARKET SUMMARY 26th February 2024 On February 26, the Indian equity indices closed lower with Nifty settling below 22,150 in a volatile session marked by widespread selling across sectors except for oil & gas, power, and capital goods. Top Gainer: LT | Top Loser: ASIANPAINT
Post Market Report POST-MARKET SUMMARY 23rd February 2024 On February 23, Indian equity benchmarks ended flat after reaching new highs in early trading, as banking stocks declined and investors exercised caution ahead of the release of GDP numbers and other data. Top Gainer: BAJAJFINSV | Top Loser: BPCL
Post Market Report POST-MARKET SUMMARY 22nd February 2024 On February 22nd, the market commenced with a tepid start influenced by mixed global signals. However, a surge in buying activity during the final hours of the session bolstered the index. Top Gainer: COALINDIA | Top Loser: INDUSINDBK
Latest GPT Healthcare IPO: Is It A Healthy Investment Opportunity? Get a detailed overview of GPT Healthcare Ltd IPO, including GMP, verdict, issue details, and the company's strengths and risks.
Post Market Report POST-MARKET SUMMARY 21st February 2024 On February 21, domestic benchmark indices halted their six-day winning streak as traders opted to lock in profits. The IT and oil & gas sectors exerted the most downward pressure on the indices. Top Gainer: TATASTEEL | Top Loser: BPCL
Latest Juniper Hotels IPO: Should You Check-In to this Luxury Hospitality Company? Get a detailed overview of Juniper Hotel Ltd’s IPO, including GMP, verdict, issue details, and the company's strengths and risks.
Post Market Report POST-MARKET SUMMARY 20th February 2024 On February 20, benchmark indices extended their winning streak to the sixth consecutive day, with the Nifty hitting new all-time highs. Top Gainer: POWERGRID | Top Loser: HEROMOTOCO
Post Market Report POST-MARKET SUMMARY 19th February 2024 On February 19, the market continued its upward trajectory for the fifth consecutive session, closing near the day's peak as the Nifty reached a fresh all-time intraday high of 22,186.65. Top Gainer: GRASIM | Top Loser: COALINDIA
Post Market Report POST-MARKET SUMMARY 16th February 2024 On February 16, the market continued its upward trajectory for the fourth consecutive session. Buoyed by favorable global signals, Indian equity indices commenced on a positive note. Top Gainer: M&M | Top Loser: AXISBANK
Latest Zee Entertainment: Profit Soars 1.4x, Stock Slides 6% | Explore the Reasons Zee's profits soar 140%, yet stock falls 6%; Explore the reasons behind the fall
Post Market Report POST-MARKET SUMMARY 15th February 2024 On February 15, amidst another volatile session, the market concluded with gains, extending its winning streak for the third consecutive session, with the Nifty crossing 21,900. Top Gainer: M&M | Top Loser: AXISBANK
Post Market Report POST-MARKET SUMMARY 14th February 2024 On February 14, amidst a highly volatile session, the market staged a sharp recovery, closing higher driven by gains in SBI and other PSU banks. Top Gainer: BPCL | Top Loser: TECHM
Latest Vibhor Steel Tubes IPO Sees High Demand; But Is It A Solid Long-Term Investment Bet? Get a detailed overview of Vibhor Steel Tubes Ltd IPO, including GMP, verdict, issue details, subscription status and the company's strengths and risks.
Post Market Report POST-MARKET SUMMARY 13th February 2024 On February 13, the Indian equity market managed to recover most of its losses from the previous session bolstered by favorable macroeconomic data, closing higher with the Nifty above 21,700, driven mainly by gains in banking stocks. Top Gainer: COALINDIA | Top Loser: HINDALCO
Post Market Report POST-MARKET SUMMARY 12th February 2024 On February 12, the Indian market opened marginally higher but failed to sustain the gains as the session progressed, with the Sensex and the Nifty closing near the day’s low ahead of CPI inflation data announcement. Top Gainer: DRREDDY | Top Loser: COALINDIA
Post Market Report POST-MARKET SUMMARY 9th February 2024 On February 9, equity benchmarks, namely the Sensex and the Nifty, concluded with slight gains amidst a volatile day of trading as investors awaited additional triggers. Top Gainer: GRASIM | Top Loser: M&M
Latest Entero Healthcare IPO: Is it a healthy investment opportunity? Get a detailed overview of Entero Healthcare Solutions Ltd’s IPO, including GMP, verdict, issue details, and the company's strengths and risks.
Post Market Report POST-MARKET SUMMARY 8th February 2024 On February 8, the Indian equity benchmarks closed significantly lower after the Reserve Bank of India (RBI) decided to maintain key interest rates unchanged. Top Gainer: SBIN | Top Loser: KOTAKBANK
Latest Indian Stock Market Falls Despite RBI’s Expected Rate Hold; Here’s Why Steady RBI Rates, Unsteady Markets: Exploring the Disconnect
Latest Capital Small Finance Bank: Should You Invest Your Capital In This IPO? Check Subscription Status, GMP, Investment Recommendation Get a detailed overview of Capital SFB’s IPO, including GMP, verdict, issue details, and the company's strengths and risks.